Evidence map›Paper›PMID 32782853›Full record

ArticleThe journal of applied research on children : informing policy for children at risk2019

Implementation costs of a multi-component program to increase human papillomavirus (HPV) vaccination in a network of pediatric clinics.

Jarrod S Eska, David R Lairson, L S Savas, Ross Shegog, C Mary Healy, Stanley W Spinner, Maria E Fernandez, Sally W Vernon

Open access · diamondAbstract read
In one paragraph

Article in The journal of applied research on children : informing policy for children at risk, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jarrod S EskaUniversity of Texas Health Science Center-Houston, Center for Health Promotion and Prevention Research, Houston, TX.
David R LairsonUniversity of Texas Health Science Center-Houston, Center for Health Services Research, Houston, TX.
L S SavasUniversity of Texas Health Science Center-Houston, Center for Health Promotion and Prevention Research, Houston, TX.
Ross ShegogUniversity of Texas Health Science Center-Houston, Center for Health Promotion and Prevention Research, Houston, TX.
C Mary HealyBaylor College of Medicine, Pediatric Medicine- Infectious Disease, Houston, TX.
Stanley W SpinnerTexas Children's Pediatrics, Houston, TX.
Maria E FernandezUniversity of Texas Health Science Center-Houston, Center for Health Promotion and Prevention Research, Houston, TX.
Sally W VernonUniversity of Texas Health Science Center-Houston, Center for Health Promotion and Prevention Research, Houston, TX.
The University of Texas Health Science Center at Houston · USBaylor College of Medicine · US

Funding

Cancer Prevention and Control Research Training and Career Development ProgramT32CA057712 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Bijal A. Balasubramanian, Maria Eulalia Fernandez · 2018 to 2026
$3.2M
NCI NIH HHS T32 CA057712
6 · The paper itself

Abstract

introductionHPV vaccination is both a clinically and cost-effective way to prevent HPV-related cancers. Increased focus on preventing HPV infection and HPV-related cancers has motivated development of strategies to increase adolescent vaccination rates. This analysis estimates the average cost associated with implementing programs aimed at increasing HPV vaccination from the perspective of the clinic decision makers. As providers and healthcare organizations consider vaccination initiatives, it is important for them to understand the costs associated with implementing these programs.

methodsHealthcare provider assessment and feedback, reminders, and education; and parent education/reminder strategies were implemented in a large pediatric clinic network between October 2015 and February 2018 to improve HPV vaccination rates. A micro-costing method was used in 2018 to prospectively estimate program implementation costs with the clinic as the unit of analysis. A sensitivity analysis assessed the effects of variability in levels of participation.

resultsAssessment and feedback reports and provider education were implemented among 51 clinics at average per clinic cost of $786 and $368 respectively. Electronic vaccination reminders were delivered to providers and parents at a per clinic cost of $824. The parent education implementation cost was $2,126 per clinic.

conclusionThe four complimentary HPV evidence-based strategies were delivered at a total cost of $157,534 or $4,749 per clinic, including staff training and participant recruitment, reaching 155,000 HPV vaccine eligible adolescents.

Identifiers

PMID32782853
PMCPMC7416872
OpenAlexW3025441231

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.